Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 3, 2002 - Issue 5
Submit an article Journal homepage
19
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous

The 93rd Annual Meeting of the American Association for Cancer Research

Dietmar W Siemann Shands Cancer Center, University of Florida, Gainesville, Florida, USA
&
J Martin Brown Stanford University, Stanford, California, USA
Pages 629-632 | Published online: 25 Feb 2005

Bibliography

  • AEBERSOLD DM, BURRI P, BEER KT et al.: et al. Expression of hypwda-inducible factor-la: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res. et al. (2001) 61:2911–2916.
  • BIRNER P, SCHINDL M, OBERMAIR A,PLANK C, BREITENECKER G, OBERHUBER G: Overexpression of hypwda-inducible factor la is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res. et al. (2000) 60:4693–4696.
  • LONCASTERJA, HARRIS AL, DAVIDSON SE et al.: et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumour oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res. et al. (2001) 61:6394–6399.
  • ALIZADEH AA, EISEN MB, DAVIS RE et al.: et al. Distinct types of diffuse large B cell lymphoma identified by gene expression profiling. Nature et al. (2000) 403:503–511.
  • KIHARA C, TSUNODA T, TANAKA T et al.: et al. Prediction of sensitivity of esophageal tumours to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res.(2001) et al. 61: 6474–6479.
  • WELSH JB, SAPINOSO LM, SU Al et al.: et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. et al. (2001) 61:5974–5978.
  • FOLKMAN J: Tumour angiogenesis: therapeutic implications. N Engl. I Med. et al. (1971) 285:1182–1186.
  • HERBST RS: Angiogenesis: current status of clinical trials. 93rd Annual Meeting et al. American Association for Cancer Research, San Francisco, CA, USA (6–10 April 2002).
  • O'REILLY MS: Angiogenesis: is it effective? 93rd Annual ll4eeting American Association for Cancer Research et al. San Francisco, CA, USA (6–10 April 2002).
  • DENEKAMP J: Vascular endothelium as the vulnerable element in tumours. Acta Radio]. Oncol et al. (1984) 23:217–225.
  • DARK GG, HILL SA, PRISE VE, TOZER GM, PETTIT GR, CHAPLIN DJ: Combretastatin A-4, an agent that displays potent and selective toxicity toward tumour vasculature. Cancer Res. et al. (1997) 57:1829–1834.
  • BLAKEY DC, WESTWOOD FR, WALKER M et al: et al. Antitumour activity of the novel vascular targeting agent ZD6126 in a panel of tumour models. Clin.Cancer Res. et al. (2002): In press.
  • WEDGE SR, KENDREW J, OGILVIE DJet al.: et al. Combination of the VEGF receptor tyrosine kinase inhibitor ZD6474 and vascular-targeting agent ZD6126 produces an enhanced antitumour response. Proc. Am. Assoc. Cancer Res. et al. (2002) 43:1081. Abstract 5351.
  • RAMASWAMY S, TAMAYO P, RIFKIN R et al: et al. Multiclass cancer diagnosis using tumour gene expression signatures. Proc. Nati Acad. Sci. USA et al. (2001) 98:15149–15154.
  • PAIK S, HAZAN R, FISHER ER et al.: et al. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. .1. Clin. Oncol. et al. (1990) 8:103–112.
  • GORRE ME, MOHAMMED M, ELLWOOD K et al.: et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science et al. (2001) 293:876–880.
  • ZWICK, et al. et al. Receptor tyrosine kinases as targets for anticancer drugs. Trends MM. Med. et al. (2002) 8(1):17–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.